Search

Las investigaciones muestran que la terapia LIT, un tipo emergente de inmunoterapia, funciona en algunos pacientes con cáncer pulmonar de células no pequeñas.

… Wednesday, May 1, 2024 Hay evidencia de que un tipo emergente de inmunoterapia llamado terapia LIT podría ser exitoso en el tratamiento de tumores más sólidos . Una investigación publicada en Cancer Discovery demuestra que este tratamiento funciona en algunos pacientes con cáncer pulmonar de células

MSK scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments.

… Thursday, January 4, 2018 Summary The breakneck speed at which cancer research and treatment is progressing is driven in large part by critical advances in technology. Our scientists and doctors have the most innovative tools at their disposal to make discoveries and develop better treatments. Here,

In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available for this disease.

… Friday, February 1, 2002 Improves Ability to Make Treatment Decisions In a development that holds promise for advancing the treatment of patients with sarcoma, researchers at Memorial Sloan Kettering Cancer Center have developed a new prognostic tool that is more accurate than any previously available

Learn about MSK's specialty in treating neuroendocrine cancers.

… Friday, March 7, 2025 The good news is that treatments for prostate cancer are helping patients live longer. But an unsettling new challenge is emerging: a different and deadlier form of the cancer called neuroendocrine prostate cancer (NEPC). Researchers at Memorial Sloan Kettering Cancer Center (MSK

A powerful therapy called an antibody-drug conjugate has been approved by the FDA for more people with bladder cancer.

… Thursday, December 11, 2025 A powerful treatment is now an option for many more people with  bladder cancer , the fifth most common form of cancer. The U.S. Food and Drug Administration (FDA) on November 21 approved a combination of two drugs —  enfortumab vedotin (Padcev®)  and an immunotherapy drug

Learn about MSK’s Adolescent and Young Adult program, which is uniquely positioned to help patients like Danielle Leventhal.

… Thursday, October 1, 2020 Tyler Wong’s girlfriend first sensed something was off. In April 2020, the couple was cuddling at home when girlfriend Joanhy felt a lump in Tyler’s belly. Tyler felt it too. Thinking it could be a hernia, Joanhy asked the urologist she works for to examine Tyler. The doctor

For cancer in the liver, interventional radiology techniques can be used to destroy tumors while minimizing damage to healthy liver tissue. 

… Tuesday, April 15, 2025 Treating liver cancer and liver metastases — cancer that has spread to the liver from elsewhere in the body — is challenging. Most patients are not candidates for surgery because there are many tumors or because the tumors are in difficult locations.   In some cases, however,

Learn how Kéara was able to maintain her quality of life after treatment for triple negative breast cancer.

… Monday, April 4, 2022 When Kéara Richardson was diagnosed with triple-negative breast cancer at just 37, she feared her life would never be the same again. But Memorial Sloan Kettering Cancer Center (MSK) offered her an innovative treatment that puts chemotherapy before breast cancer surgery . This approach

Scientists are learning how tumors develop resistance to drugs — and what can be done about it.

… Thursday, July 27, 2017 Summary Drugs targeting a particular mutation in cancer cells can be an effective form of therapy. But the beneficial effects are often short-lived as tumors quickly develop resistance. New research is casting light on how this resistance evolves and what treatment approaches

Meet Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, who is deeply satisfied with her work and delighted with her family, which will soon expand — Vikki is expecting her second child in August with her fiancée, Shauna.

… Monday, June 28, 2021 Within two minutes of meeting Victoria “Vikki” Mills, Associate Director of Research Administration Operations at Memorial Sloan Kettering, you recognize that you are in the presence of a powerful, positive force to be reckoned with, someone who is happily and energetically creating